Compound 563
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1c(F)cc(cc1F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C43H48ClF2N7O2S2/c1-51(2)20-16-33(28-56-35-9-4-3-5-10-35)49-42-39(45)24-36(25-40(42)46)57(54,55)50-43-38-19-23-53(27-41(38)47-29-48-43)34-17-21-52(22-18-34)26-31-8-6-7-11-37(31)30-12-14-32(44)15-13-30/h3-15,24-25,29,33-34,49H,16-23,26-28H2,1-2H3,(H,47,48,50)/t33-/m1/s1
- InChiKey:
WQHAHUHLZMEJLU-MGBGTMOVSA-N
External links
67980846 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 12 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.51 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 831.30 g/mol | |||
HBA | 9 | |||
HBD | 2 | |||
HBA + HBD | 11 | |||
AlogP | 5.69 | |||
TPSA | 93.70 | |||
RB | 14 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 12 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 5.51 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4340 | Navitoclax | DB12340 | |
0.4120 | GDC-0349 | DB13072 | |
0.4113 | Sulfaisodimidine | DB13283 | |
0.3819 | PF-232798 | DB14813 | |
0.3796 | Presatovir | DB12165 | |
0.3772 | Sparsentan | DB12548 | |
0.3768 | Tianeptine | DB09289 | |
0.3732 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3714 | (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | DB07666 | |
0.3708 | Quinupristin | DB01369 | |
0.3704 | 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | DB07585 | |
0.3697 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3670 | ABT-639 | DB15055 | |
0.3666 | (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE | DB08164 | |
0.3655 | Lenacapavir | DB15673 |